MARKET

ZSANQ

ZSANQ

Zosano Pharma Corp
EXMKT
0.0007
0.0000
0.00%
Closed 16:00 11/30 EST
OPEN
--
PREV CLOSE
0.0007
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
37.28
52 WEEK LOW
0.0002
MARKET CAP
3.43K
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
16 Stocks Moving in Tuesday's Pre-Market Session
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares rose 38% to $1.27 in pre-market trading following a Form 4 filing showing the purchase of 2,044,676 shares by CEO Salvatore Palella at an average price of $0.99.
Benzinga · 06/07 10:09
52 Stocks Moving In Monday's Mid-Day Session
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Benzinga · 06/06 16:11
69 Biggest Movers From Friday
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Benzinga · 06/06 09:31
ADAP, SLDP and ZSAN among mid-day movers
Gainers: Turning Point Therapeutics (TPTX) +117%. Energy Focus (EFOI) +40%. Galecto (GLTO) +25%. Adaptimmune (ADAP) +22%. Amylyx Pharmaceuticals (AMLX) +22%. AudioEye (AEYE) +20%. Sprague Resources LP (SRLP) +20%. Global Cord
Seekingalpha · 06/03 16:42
40 Stocks Moving In Friday's Mid-Day Session
 Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Benzinga · 06/03 16:07
BRIEF-Zosano Pharma Corp- On June 2 Co Got Notice From Nasdaq Indicating That Co’S Securities Will Be Delisted From Nasdaq
reuters.com · 06/03 12:17
Why Zosano Pharma Shares Are Getting Hammered Today
Zosano Pharma Corp (NASDAQ: ZSAN) shares are trading lower by 44.35% at $0.98 after the company announced it filed a voluntary petition for relief under chapter 11.
Benzinga · 06/02 18:42
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Immunic Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday.
Benzinga · 06/02 18:30
More
About ZSANQ
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company. The Company is focused on providing systemic administration of therapeutics to patients using its ransdermal microneedle system (the System). The System is designed to facilitate drug absorption into the bloodstream. The Company’s lead product candidate is Qtrypta (M207). Qtrypta is a formulation of zolmitriptan delivered utilizing its System. Zolmitriptan is a serotonin receptor agonists known as triptans and is used as an acute treatment for migraine. Qtrypta is designed for absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal (GI) tract. Its same formulation, development name C213, is the treatment to provide relief for cluster headache.

Webull offers kinds of Zosano Pharma Corp stock information, including EXMKT:ZSANQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZSANQ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZSANQ stock methods without spending real money on the virtual paper trading platform.